CRIO Secures Series A Financing to Accelerate Growth and Platform Development

11 March, 2021

Clinical Research IO (CRIO), a Boston-based technology firm offering clinical research sponsors and sites a platform to streamline clinical trials, announced the completion of a $3.5 million Series A round led by Rally Ventures.

The round allows CRIO to expand its product and engineering teams to develop the next wave of products. “Our goal has always been to streamline clinical research,” said Raymond Nomizu, company co-founder and CEO. “To do this, we need to ramp up our product and engineering teams. We have laid the groundwork with our unparalleled site network of electronic adopters, and now we want to leverage this to unlock efficiencies for sponsors and contract research organizations (CROs).”